Gastrointestinal bleeding: adjuvant pharmacotherapy for peptic ulcer bleeding.

摘要

Findings from a new, multinational, randomized, controlled trial suggest that histamine receptor 2 antagonists and PPIs are equal in their ability to control peptic ulcer rebleeding. However, several methodological issues of this study limit the conclusions that can be drawn from it.